Biogen swung to a loss as results were hurt by a double-digit decline in revenue from its core multiple sclerosis treatments.
Source link
Biogen Revenue Down as Multiple Sclerosis Sales Slide
Date:
More like thisRelated
Vietnam’s Factories Thrive Amid Trade Upheaval
Plus: Fed’s preferred inflation gauge rises; a visit to...
Russian attack hits Ukraine’s Kyiv region, killing at least 27
KYIV, Ukraine -- At least 37 people have been...